Leading HIFU Mobilizer Begins Operation on Ablatherm® Robotic HIFU Following First Quarter 2016 Purchase

LYON, France , April 25, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the sale and installation of Ablatherm Robotic HIFU at Houston Methodist Hospital , Houston, Texas . The hospital is the first location in Texas to install

LYON, France , April 28, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that The Brazilian Health Surveillance Agency (Anvisa) has approved Focal One for sale in Brazil . Marc Oczachowski , EDAP TMS Chief Executive Officer,

Company to Participate in Two Plenary Sessions and Five Poster Sessions Ablatherm Treatments Performed During "L.A. Live" Pre-AUA Symposium at USC LYON, France , May 04, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that it will

Conference Call and Webcast Scheduled for 8:30 a.m. ET

First quarter 2016 HIFU Division revenue increased 102% year-over-year 37% growth in HIFU treatment driven revenues in Q1 2016 compared to Q1 2015 €0.7 million operating profit, €1.4 million net income in first quarter 2016 510(k) application for Focal One submitted to FDA LYON, France , May 18,

Procedures Performed by Dr. Altan Ilkay

Ablatherm Robotic HIFU Deployed by HIFU USA; Initial Treatments Performed in New York by Dr. Ron Israeli and in New England by Drs. Clifford Gluck and James Lin

Conference Call and Webcast Scheduled for 8:30 a.m. ET

LYON, France , Aug. 22, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first prostate ablation treatments performed at Henry Ford Hospital in Detroit, Michigan , using the Company's FDA-cleared Ablatherm Robotic HIFU.